Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contact Us Login 
An Official Publication of the Indian Association of Oral and Maxillofacial Pathologists


 
  Table of Contents    
ORIGINAL ARTICLE  
Year : 2018  |  Volume : 22  |  Issue : 1  |  Page : 35-39
 

Elevated tissue nitric oxide in oral squamous cell carcinoma


1 Department of Oral Pathology and Microbiology, MIDSR Dental College, Ambajogai Road, Latur, Maharashtra, India
2 Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Pimpri, Maharashtra, India
3 Department of Oral Pathology and Microbiology, M A Rangoonwala Dental College and Hospital, Pune, Maharashtra, India
4 Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental School, Lohegaon, Pune, Maharashtra, India
5 Department of Oral Pathology and Microbiology, Esic Dental College, Gulbarga, Karnataka, India

Date of Submission05-Mar-2016
Date of Acceptance03-Dec-2017
Date of Web Publication13-Apr-2018

Correspondence Address:
Varsha A Sangle
Department of Oral Pathology and Microbiology, MIDSR Dental College, Ambajogai Road, Latur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jomfp.JOMFP_27_16

Rights and Permissions

 

   Abstract 

Context: Nitric oxide (NO) is a diatomic molecule that has been implicated in tumor progression of oral squamous cell carcinoma (OSCC). However, the mechanism of NO affecting tumor growth and progression remains unknown. Tumor progression has been recently received considerable attention, and there is increasing evidence of correlation of tumor biology and behavior.
Aims: We aim to evaluate tissue NO of OSCC patients and correlate these findings with grade and stage of the OSCC patients.
Materials and Methods: To count tissue nitric oxide in normal and OSCC cases. To compare the findings of tissue nitric oxide between normal and OSCC cases.
Subjects and Methods: Forty-two fresh tissue specimens from the excisional biopsy of OSCC patients and 42 tissue samples of normal healthy mucosa using ultraviolet visible spectrophotometer.
Statistical Analysis Used: Statistical analysis was done using Student's unpaired t-test and Tukey's post hoc analysis.
Results: Tissue NO level was higher in OSCC compared with control group (P < 0.01). There was an increase in NO levels with advanced clinical staging and with decreased differentiation of tumor.
Conclusions: Increased tissue NO levels in OSCC patients along with an increase in the clinical stage of the tumor and decreased differentiation of tumor indicates the association of NO with tumor growth and with staging and grading of is well recognized.


Keywords: Nitric oxide, oral cancer, oral squamous cell carcinoma


How to cite this article:
Sangle VA, Chaware SJ, Kulkarni MA, Ingle YC, Singh P, VK P. Elevated tissue nitric oxide in oral squamous cell carcinoma. J Oral Maxillofac Pathol 2018;22:35-9

How to cite this URL:
Sangle VA, Chaware SJ, Kulkarni MA, Ingle YC, Singh P, VK P. Elevated tissue nitric oxide in oral squamous cell carcinoma. J Oral Maxillofac Pathol [serial online] 2018 [cited 2019 Sep 18];22:35-9. Available from: http://www.jomfp.in/text.asp?2018/22/1/35/230042



   Introduction Top


Nitric oxide (NO) is a short-lived, endogenously produced free radical that acts as a signaling molecule and plays an important role in many regulatory functions in vivo.[1],[2] It is generated as a reaction product of the enzymatic conversion of L-arginine to L-citrulline by three isotypes of NO synthase (NOS): endothelial NOS, neuronal NOS and macrophage or inducible (iNOS). NO is also a key signaling molecule involved in many functions such as neurotransmission, vasodilation, inflammation and immunity.[3] It is also well known for its role in antitumor and antipathogen host response.[4] However, under suitable conditions, NO interacts with oxygen or other free radicals, thus generating a potent oxidant, i.e., peroxynitrite (reactive nitrogen species [RNS]). Peroxynitrite and its degradation products have been linked to interaction with a range of compounds including DNA and thus considered to be involved in pathogenesis of cancer.[3],[5] NO seems to play a part in various stages of carcinogenesis from initiation to progression.[2]

First study to identify NOS in oral squamous cell carcinoma (OSCC) was carried out by Rosbe et al.,[6] suggesting that iNOS may play a significant role in tumor growth. Numerous studies have reported significantly higher expression of iNOS or high plasma or salivary levels of NO or its products in OSCC, relating it with oral cancer pathogenesis.[6] According to Connelly et al.,[7] increased NO may result from increased NO synthesis perhaps due to the upregulation of iNOS. Release of tumor necrosis factor-alpha and interleukin-1 in consequence of tumor cells-macrophage interaction may activate NO synthesis.[7] Rasheed et al.[3] suggested potential involvement of reactive oxygen species (ROS) and RNS in the pathogenesis of head and neck squamous cell carcinoma (HNSCC) furthermore illustrated the risk of ROS-/RNS-induced damage; healthy tobacco users are exposed to, implicating their higher risk for upper aerodigestive tract cancer. After that Gokul et al.[8] concluded oxidant–antioxidant imbalance possibly considered as one of the factors responsible for pathogenesis of cancer, and Korde et al.[9] found increased total NO levels in oral precancer and cancer patients. Moreover, study suggested that oxidative DNA damage, a vital phenomenon in oral carcinogenesis, may occur due to interplay of RNS and ROS.[9] Whereas Avci et al.[10] found decreased NOS activity and NO levels in malignant oral cancer tissues as compared to benign. NO induces apoptosis and its decreased production in malignant tissues and therefore results in increased proliferation in cancer.[10] Expression of NO has also been found to be correlated with advanced grading of human mammary tumors.[11] There have been numerous studies in the past related with the role of NO in understanding its role in cancer biology much to arriving at the controversy rather than a conclusion.[12] Hence, the study was conducted to evaluate the levels of tissue NO of OSCC patients as compare with normal healthy controls and correlate these findings with grade and stage of the OSCC patients.


   Subjects and Methods Top


Ethical clearance was obtained from the institute before commencing the study. The study comprised of 84 patients, of which 42 were histopathologically diagnosed OSCC cases and the remaining 42 were controls (pericoronal tissue or excess tissue obtained during extraction). Informed consent was obtained from all the patients before the study. After thorough clinical examination of OSCC patients according to tumor node metastasis staging system (TNM classification system), TNM staging was noted.[13] The biopsy specimens from OSCC were graded histopathologically using Anneroth's multifactorial grading system [14] [Table 1]. Tissue samples of each case of histopathologically proven OSCC patients undergoing excision of oral tumors were taken for the study. The control group included 42 tissue samples of healthy normal mucosa obtained from the patients undergoing routine dental surgical procedures such as pericoronal flap surgery.
Table 1: Clinical characteristics of oral squamous cell carcinoma patients participated in the study

Click here to view


Inclusion criteria include clinically diagnosed and histopathologically confirmed cases of oral OSCC. Approximately 1 g of lesional tissue specimen was taken from the excisional biopsy.

Exclusion criteria: participants with other systemic diseases. Furthermore, participants taking any medications/antioxidant supplementation were not included in the study.

Collection of samples

Forty-two tumor tissue samples were included in the study. Sixteen cases were well-differentiated OSCC, 15 cases were moderately differentiated OSCC and 11 were poorly differentiated OSCC. Fresh tissue samples were collected at the time of surgery and kept in deep freezer. The tissue samples were thoroughly washed to remove blood stains with deionized water and then blotted dry and weighted. One gram of the sample was homogenized in 10 ml of 0.1 M cold phosphate buffer of pH 7.4 with 1 mM EDTA for 10 min, and the obtained homogenate was centrifuged at 3000 rpm for 15 min. The clear supernatant obtained was used for analysis which was performed using ultraviolet (UV) visible spectrophotometer (Thermo scientific Instruments, Spectrascan UV 2700).

Biochemical measurements

Estimation of NO was performed using the Miranda et al. method by measuring the end product, namely nitrite and nitrate.[15] The sample was deproteinized by ethanol (1:2 V/V). In this analysis, reduction of nitrate and measurement of nitrite is performed in a single step. Reduction is achieved by vanadium (III). Nitrite is immediately trapped by Griess reagent (naphthyl ethylenediamine dihydrochloride + sulfanilic acid) to give a pink-colored complex which is measured at 540 nm. To 1 ml of protein-free filtrate, 1 ml of saturated vanadium chloride (Vcl3) (400 mg dissolved in 50 ml of 1 M HCL), 0.5 ml of 0.1% (W/V) NEDD and 0.5 ml of 2% (W/V) sulfanilic acid in 5% H3PO4 were added. Blank, standard and sample blank were taken separately. All tubes were incubated at 37°C for 45 min, and optical density was read at 540 nm using UV visible spectrophotometer. The results were expressed as μmol/g protein for tissue samples. Statistical analysis was done using Student's unpaired t-test and Tukey's post hoc analysis.


   Results Top


The results obtained from the assessed parameters in OSCC patients and healthy controls are shown in [Table 2], [Table 3], [Table 4]. Significant elevation of tissue NO was found in OSCC tissue as compared with the values of the control group [Table 2]. Not only the mean calculation is more in the study group (44.67) than in the control group (14.62) but also there is a highly significant difference between mean values of calculation of both the groups (i.e., P < 0.01).
Table 2: Comparison of mean value of tissue NO levels in control group and study group

Click here to view
Table 3: Correlation between NO levels and clinical stage

Click here to view
Table 4: Comparison of mean nitric oxide levels in patients with various histopathological grading

Click here to view


When the tissue NO levels of OSCC were correlated with the TNM staging, following observations were recorded. T1N0M0 (n = 2) – 18.4 ± 0; T1N1M0 (n = 5) – 32.55 ± 8; T1N2M0 (n = 3) – 40.1 ± 9.42; T2N0M0 (n = 4) – 44.01 ± 11.25; T2N1M0 (n = 14) – 46.76 ± 8.97; T2N2M0 (n = 10) – 50.15 ± 10.96 and T3N2M0 (n = 4) – 66.65 ± 9.64. It was noted that, as the TNM stage progresses, NO level increased [Table 3].

Tissue NO level of OSCC was compared between well, moderately and poorly differentiated OSCC and it was seen that the tissue NO increased as the histopathological grading increased. The findings were recorded as well-differentiated (30.07 ± 9.12), moderately differentiated (48.07 ± 10.66) and poorly differentiated (70.75 ± 11.45) [Table 4].


   Discussion Top


The role of NO is multidimensional because of it functions as an intracellular messenger and it is also implicated as a deleterious agent in various pathological conditions including cancer.[16] Chronic inflammation can lead to the production of NO, which in turn has the potential to mediate DNA damage, directly or indirectly through the generation of more persistent RNS and ROS,[16] thereby resulting in carcinogenesis. Consequently, RNS is found to be involved in both initiation and promotion of multistep carcinogenesis.[17]

The results obtained from the study revealed a significant elevation of tissue NO in OSCC when compared to the control group (i.e., P < 0.01). These findings can be correlated with several studies like Gokul et al.,[8] who found significantly elevated NO in the tissue samples of OSCC, thereby indicating its association with tumor progression. Beevi et al.[17] and Rasheed et al.[3] showed increased plasma levels of NO in OSCC group. Increase in the level of NO and iNOS is seen in carcinomas other than OSCC such as breast cancer, cervical cancer, brain cancer, lung cancer, head and neck cancer and gastric cancer.[18],[19]

According to the Beevi et al.,[17] the antioxidant defenses are compromised in patients with oral cancer and hence the oxidative stress is increased as evidenced by elevated levels of NO products. A weak antioxidant defense system makes the mucosal cells more vulnerable to the genotoxic effect of ROS. This creates an intracellular environment more favorable for DNA damage and disease progression.[17] Accordingly, this study found significantly higher NO in the tissues of OSCC patients compared to control group. This can be explained as at lower concentration, NO acts as an antioxidant by scavenging superoxide anion (O2-) and terminating lipid peroxidation. At high local concentration, NO also forms more persistent peroxynitrite (RNS) through interacting with equal flux of O2-.3 Peroxynitrite can react with large variety of compounds including DNA, cellular lipids and proteins and thus are thought to be involved in the pathogenesis of oral cancer.[20]

The study results showed as the TNM staging of the tumor increased, tissue NO level also increased. High concentrations of NO in the tissue of patients with OSCC in the advanced stage of the disease were also obtained by Gokul et al.[8] Similar results were obtained by Korde et al.,[9] who observed a high level total NO in serum of SCC patients with clinical Stage III/IV. One of the causes of high concentrations of total NO in the tumor tissue of the advanced stage is due to the secretion of NO by cells of the immune system such as macrophages.[21] In the advanced stage, stimulated macrophages and neutrophils express iNOS and generate high amounts of NO and therefore RNOS, which can nitrosate amines.[22],[23] These nitrosamines can be formed by chemical intermediates associated with nitrosative stress and are potentially carcinogenic.[24] These observations led to the proposal that nitrosamines could be formed under conditions of chronic inflammation, which in turn can lead to cancer.[16],[25]

The most interesting and novel finding of the current study was that NO level increases with increasing histopathological grading of the tumor [Table 3]. Patel et al.[26] found the plasma NO level comparable in well to moderately differentiated OSCC but not comparable in poorly differentiated OSCC. The study results showed categorical increase in NO levels with decreased differentiation of tumor. This can be supported by studies carried out by Brennan et al.,[27] who showed that iNOS expression correlated with severity of dysplasia. Rajendran and Varkey [27],[28] immunohistochemically investigated the expression of iNOS in thirty OSMF samples and correlated it with different grades of epithelial dysplasia associated with the disease. Korde et al.[9] found increased total NO levels in oral precancer and cancer patients. Biopsies of human mammary tumors showed that there is a greater expression of iNOS in higher tumor grades which tend to be more invasive.[29] These data support the hypothesis that NO may play a critical role in the growth and spread of tumors.[16] This study is unique in itself, as this is the first study, according to the best of authors' knowledge, ever being conducted to evaluate the NO levels in different histopathological grading of the tumor.

To summarize, the study found significantly elevated levels of tissue NO in OSCC patients, so this indicates that increased NO level is involved in carcinogenesis and tumor progression.


   Conclusion Top


The data obtained from the study showed that tissue NO level is higher in OSCC when compared to normal healthy mucosa, thereby sustaining the fact that NO plays an important role in carcinogenesis. Furthermore, we obtained increase in NO levels with advanced clinical stage of the tumor and with decreased differentiation of tumor. Hence, the association of NO with tumor growth and the grading and staging of OSCC is well recognized. The regulation of tumor growth by NO represents as important new dimension in cancer biology. Hence, a futuristic treatment strategy can be designed to reduce tumor growth and can add a possible therapeutic benefit in the treatment of oral cancer. Further longitudinal studies on larger scale are necessary to establish the exact relationship between NO and cancer progression.

Acknowledgment

We would like to acknowledge Mr. More (Associate professor), biochemistry department, for giving me the opportunity to complete the research work.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.  Back to cited text no. 1
[PUBMED]    
2.
Sappayatosok K, Maneerat Y, Swasdison S, Viriyavejakul P, Dhanuthai K, Zwang J, et al. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal 2009;14:E319-24.  Back to cited text no. 2
[PUBMED]    
3.
Rasheed MH, Beevi SS, Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 2007;43:333-8.  Back to cited text no. 3
[PUBMED]    
4.
Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434-56.  Back to cited text no. 4
[PUBMED]    
5.
Davies MG, Fulton GJ, Hagen PO. Clinical biology of nitric oxide. Br J Surg 1995;82:1598-610.  Back to cited text no. 5
[PUBMED]    
6.
Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC, et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995;113:541-9.  Back to cited text no. 6
    
7.
Connelly ST, Macabeo-Ong M, Dekker N, Jordan RC, Schmidt BL. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol 2005;41:261-7.  Back to cited text no. 7
[PUBMED]    
8.
Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010;16:29-33.  Back to cited text no. 8
[PUBMED]    
9.
Korde SD, Basak A, Chaudhary M, Goyal M, Vagga A. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 2011;80:382-9.  Back to cited text no. 9
[PUBMED]    
10.
Avci A, Tüzüner-Oncül AM, Gökcan MK, Namuslu M, Oztürk A, Durak I, et al. Nitric oxide metabolism in cancerous and non-cancerous oral gingivomucosal tissues: Possible implications of nitric oxide in cancer process. J Oral Pathol Med 2009;38:304-6.  Back to cited text no. 10
    
11.
Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.  Back to cited text no. 11
    
12.
Korde Choudhari S, Sridharan G, Gadbail A, Poornima V. Nitric oxide and oral cancer: A review. Oral Oncol 2012;48:475-83.  Back to cited text no. 12
[PUBMED]    
13.
Neville BW, Damm DD, Allen CM, Bouquot JE. Epithelial pathology. In: Oral and Maxillofacial Pathology. 2nd ed. Philadelphia, PA: W. B. Saunders; 2002. p. 364.  Back to cited text no. 13
    
14.
Bhargava A, Saigal S, Chalishazar M. Histopathological grading systems in oral squamous cell carcinoma: A review. J Int Oral Health 2010;2:1-10.  Back to cited text no. 14
    
15.
Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71.  Back to cited text no. 15
[PUBMED]    
16.
Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: A review. Mutat Res 1995;339:73-89.  Back to cited text no. 16
[PUBMED]    
17.
Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004;34:379-85.  Back to cited text no. 17
[PUBMED]    
18.
Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: A review. World J Surg Oncol 2013;11:118.  Back to cited text no. 18
[PUBMED]    
19.
Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002;32:162-6.  Back to cited text no. 19
[PUBMED]    
20.
Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999;1411:385-400.  Back to cited text no. 20
[PUBMED]    
21.
Jabłońska E, Puźewska W, Charkiewicz M. Effect of IL-18 on leukocyte expression of iNOS and phospho-ikB in patients with squamous cell carcinoma of the oral cavity. Neoplasma 2006;53:200-5.  Back to cited text no. 21
    
22.
Marletta MA. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem Res Toxicol 1988;1:249-57.  Back to cited text no. 22
[PUBMED]    
23.
Miles AM, Gibson MF, Kirshina M, Cook JC, Pacelli R, Wink D, et al. Effects of superoxide on nitric oxide-dependent N-nitrosation reactions. Free Radic Res 1995;23:379-90.  Back to cited text no. 23
[PUBMED]    
24.
Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB, et al. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998;19:711-21.  Back to cited text no. 24
    
25.
Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64.  Back to cited text no. 25
[PUBMED]    
26.
Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther 2009;5:247-53.  Back to cited text no. 26
[PUBMED]    
27.
Brennan PA, Conroy B, Spedding AV. Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:624-9.  Back to cited text no. 27
[PUBMED]    
28.
Rajendran R, Varkey S. Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis. Indian J Dent Res 2007;18:94-100.  Back to cited text no. 28
[PUBMED]  [Full text]  
29.
Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995;92:4392-6.  Back to cited text no. 29
[PUBMED]    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
Print this article  Email this article
            

    

 
   Search
 
  
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Article in PDF (563 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Subjects and Methods
   Results
   Discussion
   Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed304    
    Printed1    
    Emailed0    
    PDF Downloaded122    
    Comments [Add]    

Recommend this journal

Journal of Oral and Maxillofacial Pathology | Published by Wolters Kluwer - Medknow
Online since 15th Aug, 2007